English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Genetic factors play a major role in frontotemporal dementia (FTD). The majority of FTD cannot be genetically explained yet and it is likely that there are still FTD risk loci to be discovered. Common variants have been identified with genome-wide association studies (GWAS), but these studies have not systematically searched for rare variants. To identify rare and new common variant FTD risk loci and provide more insight into the heritability of  C9ORF72- related FTD, we performed a GWAS consisting of 354 FTD patients (including and excluding  N  = 28 pathological repeat carriers) and 4209 control subjects. The Haplotype Reference Consortium was used as reference panel, allowing for the imputation of rare genetic variants. Two rare genetic variants nearby  C9ORF72  were strongly associated with FTD in the discovery (rs147211831: OR = 4.8,  P  = 9.2 × 10 −9 , rs117204439: OR = 4.9,  P  = 6.0 × 10 −9 ) and replication analysis ( P  < 1.1 × 10 −3 ). These variants also significantly associated with amyotrophic lateral sclerosis in a publicly available dataset. Using haplotype analyses in 1200 individuals, we showed that these variants tag a sub-haplotype of the founder haplotype of the repeat expansion that was previously found to be present in virtually all pathological  C9ORF72  G 4 C 2  repeat lengths. This new risk haplotype was 10 times more likely to contain a  C9ORF72  pathological repeat length compared to founder haplotypes without one of the two risk variants (~22% versus ~2%;  P  = 7.70 × 10 −58 ). In haplotypes without a pathologic expansion, the founder risk haplotype had a higher number of repeats (median = 12 repeats) compared to the founder haplotype without the risk variants (median = 8 repeats) ( P  = 2.05 × 10 −260 ). In conclusion, the identified risk haplotype, which is carried by ~4% of all individuals, is a major risk factor for pathological repeat lengths of  C9ORF72  G 4 C 2 . These findings strongly indicate that longer  C9ORF72  repeats are unstable and more likely to convert to germline pathological  C9ORF72  repeat expansions.

translational psychiatry

Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological repeat expansions